Compare Metro Healthcare Indonesia Tbk. (CARE) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Metro Healthcare Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 85× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Metro Healthcare Indonesia Tbk. is more actively traded (346.3K versus 71K). Which is the better fit depends on your goals.
| CARE | OBAT | |
|---|---|---|
Market Cap | 14.23T | 167.37B |
Volume | 346.3K | 71K |
Lot | 3.46K | 710 |
Turnover | 147.93M | 17.51M |
Average Price | 427.18 | 246.63 |
Value | 147.93M | 17.51M |
Indicative Equilibrium Price | 428 | 246 |
Indicative Equilibrium Volume | 10 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Metro Healthcare Indonesia Tbk.
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
